Back to Search

ROBERT L ALT MD

MD

Internal Medicine Physician

NPI: 1578500872Individual

Specialties, Licenses & Credentials

Internal Medicine PhysicianPrimary

Internal Medicine

Code: 207R00000X

29331-020(WI)

Research & Publications (13)

Where the boys are not: a brief overview of male preventive health.
PMID 12152512·WMJ·2002
6-review
Men's health issues: fable, reality check and bright signs on the horizon.
PMID 12152510·WMJ·2002
8-other
ABCG2 expression is correlated neither to side population nor to hematopoietic progenitor function in human umbilical cord blood.
PMID 19101070·Exp Hematol·2009
7-preclinical
All-trans retinoic acid arrests neuroblastoma cells in a dormant state. Subsequent nerve growth factor/brain-derived neurotrophic factor treatment adds modest benefit.
PMID 18639684·J Pediatr Surg·2008
8-other
The case for a metabolic stem cell niche.
PMID 18216460·Cells Tissues Organs·2008
6-review
WNT-conditioned media differentially affect the proliferation and differentiation of cord blood-derived CD133+ cells in vitro.
PMID 17316380·Differentiation·2007
7-preclinical
Tetracycline-controlled transgenic targeting from the SCL locus directs conditional expression to erythrocytes, megakaryocytes, granulocytes, and c-kit-expressing lineage-negative hematopoietic cells.
PMID 16675709·Blood·2006
7-preclinical
Low zone tolerance induced by systemic application of allergens inhibits Tc1-mediated skin inflammation.
PMID 16675348·J Allergy Clin Immunol·2006
7-preclinical
Levocetirizine in children: evidenced efficacy and safety in a 6-week randomized seasonal allergic rhinitis trial.
PMID 15853959·Pediatr Allergy Immunol·2005
3-trial
B cells are not required for T cell priming in low zone tolerance to contact allergens and contact hypersensitivity.
PMID 15376190·Eur J Immunol·2004
7-preclinical
Safety of various dosage regimens during induction of sublingual immunotherapy. A preliminary study.
PMID 12444323·Int Arch Allergy Immunol·2002
3-trial
Men's health matters: a gender in crisis.
PMID 11491041·WMJ·2001
4-observational
Therapeutic application of T cell receptor mimic peptides or cDNA in the treatment of T cell-mediated skin diseases.
PMID 10871747·Gene Ther·2000
7-preclinical

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
1821 S STOUGHTON RD
MADISON, WI 53716
Practice locations map

Location

DEAN HEALTH SYSTEMS, INC.

1821 S STOUGHTON RD, MADISON, WI
(608) 260-6000

Quick Facts

NPI
1578500872
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
1
Locations
1
Publications
13

Are you this provider?

Claim Your Profile